Evidence map›Paper›PMID 42190647›Full record

ArticleThe American journal of tropical medicine and hygiene2026

Expert Recommendations to Strengthen Chikungunya Outbreak Surveillance and Reporting for Traveler Health Protection.

Daniel C Payne, Karoun H Bagamian, Jeffery Goad, Nathan D Grubaugh, Michael A Johansson, Moritz U G Kraemer, Eyal Leshem, Francesca F Norman, Alfonso J Rodríguez-Morales, Henrik Salje and 6 more

Abstract read
In one paragraph

Article in The American journal of tropical medicine and hygiene, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Daniel C PayneDivision of Infectious Diseases, Cincinnati Children's Hospital Medical Center and University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.
Karoun H BagamianBagamian Scientific Consulting, LLC, Gainesville, Florida, USA.
Jeffery GoadSchool of Pharmacy, Chapman University, Irvine, California, USA.
Nathan D GrubaughDepartment of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, Connecticut, USA.
Michael A JohanssonBouvé College of Health Sciences, Northeastern University, Boston, Massachusetts, USA.
Moritz U G KraemerPandemic Sciences Institute and Department of Biology, University of Oxford, Oxford, England.
Eyal LeshemCenter for Travel Medicine and Tropical Diseases, Sheba Medical Center, Tel Hashomer, Israel.
Francesca F NormanNational Referral Unit for Tropical Diseases, Infectious Diseases Department, Hospital Universitario Ramón y Cajal, Ramón y Cajal Institute for Health Research (IRYCIS), Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Madrid, Spain.
Alfonso J Rodríguez-MoralesFaculty of Health Sciences, Universidad Científica del Sur, Lima, Peru.
Henrik SaljeDepartment of Genetics, University of Cambridge, Cambridge, England.
Stephen ThomasGlobal Health Institute, State University of New York Upstate Medical University, Syracuse, New York, USA.
Scott C WeaverInstitute for Human Infections & Immunity, University of Texas Medical Branch, Galveston, Texas, USA.
Lindsey A LaytnerBagamian Scientific Consulting, LLC, Gainesville, Florida, USA.
Rebecca SturgisDivision of Infectious Diseases, Cincinnati Children's Hospital Medical Center and University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.
Suzanne K ScheeleEpidemiology and Vaccine Access, Bavarian Nordic, Durham, North Carolina, USA.
Davidson H HamerDepartment of Global Health, Boston University School of Public Health, Boston, Massachusetts, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chikungunya, a debilitating mosquito-borne disease caused by chikungunya virus, has surged dramatically in the past two decades. Chikungunya outbreaks can intensify rapidly, with infections posing a significant endemic health burden in tropical/subtropical areas and for travelers. Health professionals require timely and accurate outbreak information to adequately protect travelers and assess chikungunya risk. However, detection is often insufficient in the areas most susceptible to outbreaks, leading to diagnostic and reporting delays. Consequently, travelers are often unaware of increased chikungunya infection risk at their destination. We assessed chikungunya surveillance and reporting resources, and we developed expert recommendations for traveler health protection. Because data-reporting cadences, reliability, and availability vary, we organized structured activities and convened an expert panel to compare these resources and evaluate their strengths and weaknesses. We provide a synthesis of the expert panel discussion and provide recommendations on how to improve chikungunya surveillance and risk communication to travelers. Assessing outbreak risk requires using multiple local and international reporting resources because no single resource contains all of the necessary information. The panelists identified several challenges regarding chikungunya surveillance and outbreak reporting: inadequate chikungunya surveillance infrastructure and diagnostic capacity; varying case definitions; limited understanding of the local health care context; inadequate awareness of chikungunya in health care settings; and restricted or delayed access to real-time surveillance data. As chikungunya risk increases worldwide, greater attention and resources are needed to improve timely, sensitive, and specific diagnostic testing and rapid communication to health care workers and travelers, particularly in resource-poor regions where outbreaks occur.

Indexed as

Chikungunya FeverDisease OutbreaksPopulation SurveillanceTravelAnimalsChikungunya virusHumans

Identifiers

PMID42190647
PMCPMC13326870

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.